Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Avelumab

EU orphan designation number: EU/3/16/1798   
Active ingredient: Avelumab
Indication: Treatment of gastric cancer
Sponsor: Merck Europe B.V.
Gustav Mahlerplein 102, lto Toren, 1082 MA Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/12/2016 Orphan designation EMA/OD/170/16 (2016)8698 of 12/12/2016
27/06/2018 Transfer of orphan designation EMA/OD/170/16/T/01 (2018)4090 of 25/06/2018